Single-center, Double-blind, Randomized, Placebo-controlled Trial to Explore the Efficacy and Safety of Lymphoblock for Prevention of Lymphorrhea in Patients With Thoracoabdominal Aorta Repair.
Randomized, double-blind, placebo-controlled study will determine the clinical efficacy and safety of Lymphoblock in the prevention of postoperative retroperitoneal chylo-/lymphorrhoea in patients with open surgical treatment of the thoracoabdominal aorta. It is planned to recruit 138 clinical observations. Efficacy will be evaluated based on clinical and laboratory data.
- EligibilityCriteria: Inclusion Criteria:  patient in thoracoabdominal or abdominal aorta repair underwent retroperitoneal aortic access  Exclusion Criteria:  refusal to participate in the study - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - MaximumAge: 75 Years - StdAgeList: Adult, Older Adult